Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.1083 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0176 | 0.459 | 0.6051 |
Onchocerca volvulus | 0.005 | 0.1129 | 0.1733 | |
Loa Loa (eye worm) | hypothetical protein | 0.0246 | 0.6503 | 0.9127 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.1083 | 1 |
Plasmodium vivax | SET domain protein, putative | 0.0031 | 0.0604 | 0.0372 |
Schistosoma mansoni | hypothetical protein | 0.005 | 0.1129 | 1 |
Trypanosoma brucei | pyruvate kinase 1 | 0.0035 | 0.0704 | 0.5 |
Echinococcus multilocularis | pyruvate kinase | 0.0018 | 0.0241 | 0.037 |
Echinococcus multilocularis | pyruvate kinase | 0.0027 | 0.0504 | 0.0775 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0604 | 0.0848 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0268 | 0.7125 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0216 | 0.5694 | 0.7991 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0031 | 0.0604 | 0.5352 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.0035 | 0.0704 | 0.0989 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0268 | 0.7125 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0176 | 0.459 | 0.6051 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0373 | 1 | 1 |
Onchocerca volvulus | Glucosylceramidase homolog | 0.0176 | 0.459 | 0.7045 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0035 | 0.0704 | 0.1081 |
Brugia malayi | O-Glycosyl hydrolase family 30 protein | 0.0268 | 0.7125 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0373 | 1 | 1 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0035 | 0.0704 | 0.5 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0183 | 0.4789 | 0.7351 |
Echinococcus granulosus | pyruvate kinase | 0.0035 | 0.0704 | 0.1083 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0246 | 0.6503 | 1 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.005 | 0.1129 | 0.1585 |
Brugia malayi | Pyruvate kinase, muscle isozyme | 0.0035 | 0.0704 | 0.0989 |
Echinococcus granulosus | pyruvate kinase | 0.0018 | 0.0241 | 0.037 |
Loa Loa (eye worm) | pyruvate kinase-PB | 0.0024 | 0.0416 | 0.0584 |
Schistosoma mansoni | pyruvate kinase | 0.0035 | 0.0704 | 0.6239 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0035 | 0.0704 | 0.1081 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0373 | 1 | 1 |
Plasmodium falciparum | pyruvate kinase | 0.0035 | 0.0704 | 0.0475 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.1083 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.005 | 0.1129 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0031 | 0.0604 | 0.0929 |
Onchocerca volvulus | 0.0031 | 0.0604 | 0.0928 | |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0373 | 1 | 0.5 |
Giardia lamblia | Pyruvate kinase | 0.0035 | 0.0704 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0268 | 0.7125 | 1 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0035 | 0.0704 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0031 | 0.0604 | 0.5352 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0186 | 0.485 | 0.6457 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0373 | 1 | 1 |
Loa Loa (eye worm) | O-glycosyl hydrolase family 30 protein | 0.0268 | 0.7125 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.1083 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.0018 | 0.0241 | 0.037 |
Leishmania major | pyruvate kinase | 0.0035 | 0.0704 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.1083 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0031 | 0.0604 | 0.5352 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0373 | 1 | 1 |
Leishmania major | pyruvate kinase | 0.0035 | 0.0704 | 0.5 |
Echinococcus granulosus | pyruvate kinase | 0.0035 | 0.0704 | 0.1083 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0176 | 0.459 | 0.6051 |
Onchocerca volvulus | 0.0246 | 0.6514 | 1 | |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0031 | 0.0604 | 0.0929 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0035 | 0.0704 | 0.5 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0373 | 1 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0031 | 0.0604 | 0.0848 |
Loa Loa (eye worm) | pyruvate kinase | 0.0035 | 0.0704 | 0.0989 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.0035 | 0.0704 | 0.5 |
Echinococcus multilocularis | pyruvate kinase | 0.0035 | 0.0704 | 0.1083 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0035 | 0.0704 | 0.1081 |
Loa Loa (eye worm) | pyruvate kinase | 0.0035 | 0.0704 | 0.0989 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0176 | 0.459 | 0.6051 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0246 | 0.6503 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0183 | 0.4789 | 0.6721 |
Echinococcus granulosus | pyruvate kinase | 0.0018 | 0.0241 | 0.037 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0176 | 0.459 | 0.6051 |
Schistosoma mansoni | pyruvate kinase | 0.0035 | 0.0704 | 0.6239 |
Echinococcus multilocularis | pyruvate kinase | 0.0018 | 0.0241 | 0.037 |
Toxoplasma gondii | pyruvate kinase PyKII | 0.0018 | 0.0241 | 0.342 |
Brugia malayi | Pre-SET motif family protein | 0.0216 | 0.5694 | 0.7991 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0031 | 0.0604 | 0.0929 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0031 | 0.0604 | 0.8579 |
Echinococcus multilocularis | pyruvate kinase | 0.0035 | 0.0704 | 0.1083 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0176 | 0.459 | 0.6051 |
Trichomonas vaginalis | set domain proteins, putative | 0.0246 | 0.6514 | 0.9049 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0416 | 0.0584 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0031 | 0.0604 | 0.5352 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0186 | 0.485 | 0.6457 |
Schistosoma mansoni | pyruvate kinase | 0.0018 | 0.0241 | 0.2134 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0704 | 0.0989 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0268 | 0.7125 | 1 |
Brugia malayi | Pyruvate kinase, alpha/beta domain containing protein | 0.001 | 0.004 | 0.0057 |
Loa Loa (eye worm) | pyruvate kinase | 0.0035 | 0.0704 | 0.0989 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0268 | 0.7125 | 1 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.003 | 0.0573 | 0.0881 |
Brugia malayi | hypothetical protein | 0.0246 | 0.6503 | 0.9127 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0176 | 0.459 | 0.6051 |
Echinococcus multilocularis | pyruvate kinase | 0.0018 | 0.0241 | 0.037 |
Plasmodium vivax | pyruvate kinase, putative | 0.0035 | 0.0704 | 0.0475 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.0035 | 0.0704 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0268 | 0.7125 | 1 |
Brugia malayi | N-terminal motif family protein | 0.0183 | 0.4789 | 0.6721 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 100 uM | Inhibition of ancreatic cholesterol esterase using using p-nitrophenylacetate or cholesteryl [1-14C]-oleate as substrates | ChEMBL. | No reference |
IC50 (binding) | > 100 uM | Inhibition of ancreatic cholesterol esterase using using p-nitrophenylacetate or cholesteryl [1-14C]-oleate as substrates | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.